Loading…
Loading…
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (“Cinemark”) (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced that it will report its third quarter 2026 operating results and associated executive commentary pre-market and host a webcast to discuss the results on:Tuesday, November 3, 20268:30 a.m. Eastern TimeInterested parties can listen to the call via live webcast.Please access 5-10 minutes before the call:https://event.c.
Cinemark Holdings rated BUY after record 2Q26 EBITDA, with 3Q26 earnings expected to accelerate on a robust summer box office. Box office receipts and premium large-format expansion drive revenue growth and operating leverage, supported by strong film lineups into 2027. CNK's market share gains, premiumization, and healthy balance sheet underpin superior profitability versus AMC, yet shares trade at a 29% EV/EBITDA discount.
Movie theater stocks have become one of the standout trades of the year, with AMC Entertainment (NYSE:AMC) shares leading the group. AMC shares are up 83% year to date (YTD) to $2.86, the largest gain among the biggest U.S.
Heico, Cinemark and Oscar Health are three stocks showing relative strength against the broader market.
CNK's shares rally as record summer box office, premium-format expansion and rising earnings estimates strengthen its appeal as a buying opportunity.
Cinemark (CNK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
NUE, CNK and MED made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 14, 2026.
AII, NUE and CNK made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 14, 2026.